Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.
Alpha Fusion has raised $6.9M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Alpha Fusion's investors include SBI Investment, Global Brain Corporation, Osaka University Venture Capital, Sumitomo Heavy Industries, D3.
Alpha Fusion is headquartered in Osaka, Japan.
Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.
Alpha Fusion is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alpha Fusion — Funding & Investors." VCBacked, October 8, 2024, https://www.vcbacked.co/company/alpha-fusion. Accessed July 20, 2026.
VCBacked. (2024). Alpha Fusion — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/alpha-fusion
{{cite web |title=Alpha Fusion — Funding & Investors |url=https://www.vcbacked.co/company/alpha-fusion |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated